Using a fan during summer could help you sleep better – and it's not just about the temperature
While a whirring fan may provide some much-needed relief from sky-high dew points and lingering heat, they can also alleviate noise pollution.
'Tuning out environmental noises with the soothing sound of white noise from a fan can significantly improve sleep quality,' the Better Sleep Council advises.
In a survey of Americans' sleep, 27 percent of respondents who considered themselves to be excellent sleepers reported regularly sleeping with a fan in their bedroom.
But, there are even more benefits. Here's what to know...
Using a fan may help to improve the quality of your sleep. (Getty Images/iStock)
It's not just white noise
With people awake longer hours during summer months, there's more noise pollution, or unwanted and disturbing sound.
Fans can help to fight the negative effects of noise pollution, such as sleep disruption, insomnia, and chronic health conditions that include heart disease, depression, anxiety, and cognitive impairment.
Loud noises can even trigger an acute stress response commonly known as 'fight-or-flight,' according to Peter James, an associate professor at Harvard T.H. Chan School of Public Health.
James and colleagues found in 2017 that low-income communities and areas with a large proportion of nonwhite residents are disproportionately impacted by traffic noise. So are people who live in urban areas.
'We've made these conscious or subconscious decision as a society to put minority-race communities who have the least amount of political power in areas near highways and airports,' he told Kaiser Health News.
Tuning out these sounds can significantly improve sleep quality. Fans produce a consistent ambient noise that can 'mask some of the lower-level fluctuations in background noise so that you're not alerted to those signals,' Norah Simpson, a clinical professor of psychiatry and behavioral sciences at Stanford University, told The Washington Post.
White noise may also make the ringing sound associated with tinnitus less noticeable. The audiological and neurological condition impacts approximately 10 percent of American adults, according to the National Institute on Deafness and Other Communication Disorders.
There are other more obvious benefits
For one, fans can clear the air in a room.
'If you're blowing a fan on you to help you cool, that's great. But if you're in a stuffy room, you actually want the fan to blow out all the carbon dioxide that has built up in the room,' John Saito, spokesperson for the American Academy of Sleep Medicine, told The Post.
Exposure to too much carbon dioxide in a room may put people at an increased risk of tiredness, headache, eye irritation, sore or dry throat, dizziness, and congestion.
Secondly, fans cannot lower the temperature in the room, but they can make you feel more cool. Fans are able to cool people by displacing warmer air, and helping to evaporate sweat from the skin, according to NASA.
Make sure to get the right fan! Oscillating fans may prevent air flow from moving directly toward you as you sleep (Getty Images/iStock)
Getting the seven hours of sleep adults need to stay healthy is greatly impacted during hot and humid summers. And the season is becoming even hotter due to the impacts of human-caused climate change.
Hot and bothered Americans already lose over an hour of sleep each week in summer, according to SleepScore Labs, impacting an already shorter average sleep duration.
'In summer, the delta between the sleep we need and the sleep we get widens,' Nate Watson, SleepScore Labs' Sleep Advisory Board chair, told Sleep.com. 'Warmer temperatures' impact on our ability to fall asleep along with increased social activities competing with sleep time are likely additional factors impacting these findings."
Bear this in mind
Oscillating fans prevent air flow from moving in just one direction, according to Healthline.
The publication notes that fans can circulate dust and pollen, dry out your eyes and skin, and result in muscle aches.
Furthermore, the Centers for Disease Control and Prevention recommends using fans only if indoor temperatures are less than 90 degrees.
'In temperatures above 90 degrees, a fan can increase body temperature,' the agency said.
'When you're sitting in front of a fan, it makes you feel cool. But just because you feel cool doesn't mean that it's exactly reducing the burden that your body faces,' Glen Kenny, a physiology professor at the University of Ottawa, told InsideClimate News.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Forgotten 'weeds' prove a culinary hit in Kenya
Once dismissed as wild weeds and a "poor man's food", indigenous leafy vegetables in Kenya are now becoming much more common - grown on farms, sold in markets and gracing the menus of restaurants. At the busy Skinners Restaurant in Gachie just outside the capital, Nairobi, one employee says demand for "kienyeji" - as all local vegetable varieties are known - is higher than for other greens. "Many people ask for kienyeji when they come here," Kimani Ng'ang'a tells the BBC, despite the fact the restaurant charges extra for them as he says they are harder to source. Vegetables like cabbage, spinach, kale and spring greens, introduced by colonial authorities before the 1960s, are more readily available and cheaper. Spring greens are known as "sukumawiki", meaning "stretch the week" in Swahili, reflecting how they have become a daily staple. But diners in Gachie are part of the growing wave of Kenyans who see the benefits of eating local, organically produced nutrient-rich varieties of greens. "It detoxifies the body and is good in weight loss," says James Wathiru, who ordered "managu" - or African nightshade. Another person told me: "It's all about its taste, which is better." According to horticulture professor Mary Abukutsa-Onyango, this trend is reflected in government data and some of the health benefits are backed by research. Over the last 10 years, production of local greens has doubled - with 300,000 tonnes produced by local farmers last year, she says. It is a remarkable change in attitudes, given people used to look down on traditional crops as inferior - not realising they were often more resistant to diseases and pests, meaning they can be grown organically. In the 1980s, when Prof Abukutsa-Onyango began her studies, she says she was perplexed to find them referred to as "weeds". "We never learnt about African indigenous vegetables. They were calling amaranth 'pigweed' [and] spider plant, they were calling it 'spider weed'," she tells the BBC. Her postgraduate research on traditional plants was also tricky as there was no literature about them, but she persevered and now works with the government to promote them for food security. She says managu and other local vegetables like "mrenda" (jute mallow) and "terere" (amaranth) have more essential minerals than sukumawiki, as well as "higher levels of vitamin A and C [and] antioxidants" that boost immunity and reduce the risk of disease. Some varieties also contain protein, making them an excellent option for vegetarians. She notes for instance that 100g (3.5 ounces) of mrenda - known for its distinctive slimy texture when cooked - contains more nutrients than a similar portion of common cabbage. The progress people like Prof Abukutsa-Onyango have made in promoting the diversity and knowledge of indigenous vegetables was acknowledged by Unesco in 2021, when the UN cultural agency commended the East African nation for the "safeguarding of intangible cultural heritage" that had been threatened by "historical factors and the pressures of modern lifestyles". It noted that Kenya had begun a project in 2007 involving scientists and local communities to record an inventory of traditional foods, which now includes 850 indigenous plants and their local names. Some of these vegetables are eaten nationwide, while others are specific to certain areas or communities. But sukumawiki, first introduced to Kenya from the Mediterranean as animal feed, is still favoured by many farmers - with more than 700,000 tonnes produced in 2023 - more than double the volume of all indigenous leafy vegetables combined. Francis Ngiri, who used to farm in Kirinyaga in central Kenya where cabbages are a mainstay crop, explains that this is because, especially during the 1970s, those growing imported leafy vegetables used fertilisers and pesticides that damaged the local biodiversity. Today, he tells the BBC, only the introduced varieties thrive as the soil has become too acidic to support many native species. Determined to do something so they would not be lost forever, Mr Ngiri moved his operation to Kenya's Rift Valley - an area he considers relatively untouched by chemical contamination - so he could practise organic farming of indigenous crops. On a four-acre (1.6 hectare) farm in Elementaita, he began with 14 native varieties in 2016. Today that has grown to 124, many of which he has sourced through seed exchanges with fellow farmers. His farm now draws visitors from across Kenya and neighbouring countries. They come to see how he collaborates with 800 other regional farmers, who also grow organic food for local markets, to preserve and regenerate "forgotten plants", ensuring their genetic diversity is safeguarded for future generations. Nonetheless by swapping seeds, Mr Ngiri and his colleagues are actually breaking the law as the government only allows the planting of certified seeds. This controversial law was introduced in 2012 with the intention of protecting farmers from purchasing poor quality seeds. Wambui Wakahiu, who trains farmers on seed conservation, says such policies do not support efforts to save indigenous crop varieties, as their seeds are not available in farm-supply shops. She works for Seed Savers Network, a non-governmental organisation with 400,000 members, which helps establish seed banks for farmers to safely store and preserve their local seeds. Her team found that more than 35 traditional plant varieties had been "completely lost" in one county alone because of the law. "If [the farmers] focus more on the exotic [foreign] seeds, then the traditional seeds continue going away. And we have seen most of them go extinct," she tells the BBC. Mr Ngiri and others who have been exchanging seeds have not been pursued by the authorities, but he says the law does prevent them from marketing them: "If I can't sell the seed, I don't own it." And getting certification is a rigorous, costly process, as seeds need to be tested in a laboratory for their purity and things like how well they germinate. Dr Peterson Wambugu, a chief research scientist with the national gene bank at the Kenya Agricultural and Livestock Research Organization (Kalro), acknowledges that under the current law, the exchanging and sale of uncertified seeds - including those saved by farmers - is criminalised. However, he points out that this is at odds with the International Treaty on Plant Genetic Resources for Food and Agriculture, of which Kenya is a signatory, as it sets out farmers' rights to save, use and exchange their seeds. The national gene bank has been working with other groups to draft regulations through the agriculture ministry to align Kenyan law with the treaty. The proposals, once passed by parliament, will allow farmers to exchange their seeds "without fearing that what they are doing is criminal", he tells the BBC. However, the selling of such seeds would still remain outlawed - something Dr Wambugu knows means the journey to full acceptance of indigenous crops continues. For Priscilla Njeri, a vegetable vendor in the bustling Wangige market in Kiambu county just outside Nairobi, there is no turning back, as she can see first-hand that indigenous greens are now the most popular with her customers - something she puts down to the media campaigns that promote them. "The most preferred are managu, terere and kanzira [African kale] - which is popular for those who have sensitive stomachs as it has no gas," she tells the BBC. "But all the kienyeji greens are good because they have a better taste." You may also be interested in: The Kenyan enthralled by the healing power of plants Kenyan vigilantes taking on avocado gangs The ancient lore of the humble Nigerian yam Jollof Wars: Who does West Africa's iconic rice dish best? Podcast: Africa's forgotten foods Go to for more news from the African continent. Follow us on Twitter @BBCAfrica, on Facebook at BBC Africa or on Instagram at bbcafrica BBC Africa podcasts Africa Daily Focus on Africa
Business Wire
6 hours ago
- Business Wire
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
IRVINE, Calif.--(BUSINESS WIRE)--Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evaluating CBT-004 ophthalmic solution in patients with vascularized pinguecula and associated conjunctival hyperemia. "There is a significant unmet need for patients suffering from symptomatic pinguecula, as current therapies are largely off-label and may carry safety concerns with long-term use," said Dr. John Hovanesian, Clinical Professor of Ophthalmology and recognize Share Key Phase 2 Results Primary Endpoint Achieved: Both investigated concentrations of CBT-004 demonstrated statistically significant improvements in conjunctival hyperemia compared to vehicle at Day 28, as assessed by an independent reading center using digital imaging. Rapid Onset and Sustained Efficacy: Significant improvements were observed as early as Day 7 with the highest investigated concentration CBT-004 , with benefits persisting through the 28-day treatment period. Significant Symptom Relief: Both CBT-004 concentrations showed statistically significant improvements in five common patient-reported symptoms including burning/stinging, itching, foreign body sensation, eye discomfort, and pain compared to vehicle. Excellent Safety Profile: No treatment-related adverse events were observed. Most adverse events were mild to moderate. No clinically meaningful changes in visual acuity or intraocular pressure were reported. Addressing a Significant Unmet Medical Need Vascularized pinguecula affects millions of Americans and represents a substantial unmet medical need in ophthalmology. This common, benign conjunctival growth can become problematic when it develops abnormal blood vessels and inflammation, which can lead to persistent redness, irritation, pain, and foreign body sensation. Current management options are limited, with many patients relying on off-label corticosteroids or surgical excision, both of which carry significant limitations and potential complications. Study Design and Results The multicenter, randomized, double-masked, vehicle-controlled Phase 2 study enrolled 88 adult patients with vascularized pinguecula and associated conjunctival hyperemia. Participants were randomized to receive one of two concentrations of CBT-004, or vehicle. The primary endpoint was the change from baseline in conjunctival hyperemia at Day 28, as measured by an independent reading center using standardized digital imaging protocols. Expert Commentary "There is a significant unmet need for patients suffering from symptomatic pinguecula, as current therapies are largely off-label and may carry safety concerns with long-term use," said Dr. John Hovanesian, Clinical Professor of Ophthalmology and recognized key opinion leader in anterior segment disease. "The results from this trial are exciting, as they demonstrate that a targeted, non- steroidal therapy can meaningfully improve both the clinical signs and symptoms that impact patients' quality of life." "As a principal investigator in this study, I was impressed by the consistency and magnitude of improvement in both objective redness and patient-reported discomfort with CBT-004," commented Dr. Sherif El-Harazi, Medical Director at Global Research Management. "The safety profile was excellent, and I believe this therapy could represent a meaningful advance for our patients with vascularized pinguecula." About CBT-004 CBT-004 is a novel, preservative-free topical ophthalmic solution containing a potent and selective inhibitor of vascular endothelial growth factor (VEGF) receptors and platelet-derived growth factor (PDGF) receptors. The formulation is specifically designed to reduce abnormal blood vessel growth and inflammation associated with vascularized pinguecula while minimizing potential ocular surface toxicity through its preservative- free composition. Next Steps and Regulatory Strategy Based on these positive Phase 2 results, Cloudbreak Pharma Inc. plans to advance CBT-004 into Phase 3 development and initiate discussions with the U.S. Food and Drug Administration (FDA) to establish the regulatory pathway toward potential approval. The company anticipates providing updates on Phase 3 study design and timing in the coming months. Market Opportunity The vascularized pinguecula market represents a significant commercial opportunity with limited therapeutic options. The prevalence of pinguecula increases with age and UV exposure, affecting a substantial portion of the aging population. With no FDA-approved treatments specifically indicated for this condition, CBT-004 has the potential to become a category-defining therapy in this underserved market. About Cloudbreak Pharma Inc. Cloudbreak Pharma Inc. is a clinical-stage ophthalmology company dedicated to developing innovative therapies for ocular surface diseases with high unmet medical need. The company's pipeline focuses on novel treatments targeting inflammation, vascularization, and other pathological processes affecting the ocular surface. Cloudbreak is committed to improving outcomes for patients with challenging eye conditions through scientifically-driven therapeutic development. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the potential therapeutic benefits of CBT-004, the company's clinical development plans, regulatory strategy, and market opportunity. These forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could cause actual results to differ include, but are not limited to, the uncertainty of clinical trial results, regulatory approval processes, competitive developments, and other risks detailed in the company's filings. The company undertakes no obligation to update these forward-looking statements except as required by law. Please note that the information contained in this press release may not be complete. For further details about Cloudbreak Pharma Inc., and our drug candidates, please refer to our company's website (at
Business Upturn
7 hours ago
- Business Upturn
Veteran Inventor Announces New Air Purification System That Splits CO₂, Produces Oxygen, and May Support Health and Ozone Recovery
Seminole, FLORIDA , July 20, 2025 (GLOBE NEWSWIRE) — Clean Air Electric Filter announces the launch of its Conducted Direct Current (CDC) air purification system, a technology developed over 12 years by disabled American veteran Gal Joe Nahum. The system is designed to split carbon dioxide (CO₂) into carbon and oxygen, generate ozone through negative ions, and may offer additional wellness benefits, including support for nutrient absorption. Gal Joe Nahum Photo Advertisement The CDC filtration system works by passing direct current through the air, targeting CO₂ molecules. As the air flows through the unit, the current splits the carbon from the oxygen atoms. Carbon is internally collected, and purified oxygen is released, contributing to cleaner indoor and outdoor environments. A unique feature of this system is its generation of negative ions (–ions). These ions are naturally found in environments like waterfalls, where the friction of water hitting air produces a charge. 'Negative ions bind to positively charged particles, such as dust and pollutants, pulling them to the ground and purifying the air,' said Gal Joe. Nahum. 'If they reach the upper atmosphere, they may convert into ozone. Given the ozone depletion over Antarctica, restoring this layer is a priority for global health.' Beyond air purification, Gal Joe Nahum suggests the CDC technology may also have future use in health and wellness. 'There is a theory that this technology could assist the body in absorbing essential nutrients like vitamin D and calcium, potentially benefiting bones, nails, and teeth,' he noted. While this aspect remains under exploration, the concept reflects Nahum's commitment to broader applications for public benefit. The system is also being paired with a renewable energy source. Nahum is developing a transformer that harvests atmospheric energy, such as lightning and thunder, and converts it into direct current, allowing the filtration system to operate sustainably off-grid. Gal Joe Nahum, who served during the Desert Storm conflict, has dedicated over a decade of his life to the development of this technology. However, his efforts have not always been met with support. 'I came to NASA with this technology in good faith, hoping to collaborate,' he said. 'But I was dismissed simply because I wasn't part of the system. They forgot that some of the greatest innovators, like the Wright brothers, didn't have formal credentials. Without them, NASA wouldn't even exist.' His work is also chronicled in his book, which explores his scientific innovations and space-related concepts. Learn more at . Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
